Publications
The feasibility of pressurised intraperitoneal aerosolised virotherapy (PIPAV) to administer oncolytic adenoviruses Ghent University
Immune Suppression during Oncolotyic Virotherapy for High-Grade Glioma; Yes of No? KU Leuven
Oncolytic virus-induced cell death and immunity: a match made in heaven? Vrije Universiteit Brussel
Our understanding of the mechanisms responsible for cancer development has increased enormously over the last decades. However, for many cancers, this has not been translated into a significant improvement in overall survival, and overall mortality remains high. Treatment for many malignancies remains based on surgery, chemotherapy, and radiotherapy. Significant progress has been made toward the development of more specific, more potent, and ...
Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells Vrije Universiteit Brussel
NEWCASTLE DISEASE VIROTHERAPY, A NOVEL IMMUNOTHERAPEUTIC APPROACH FOR HIGH GRADE GLIOMA KU Leuven
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death KU Leuven
Viruses of protozoan parasites and viral therapy: is the time now right? Institute of Tropical Medicine
Infections caused by protozoan parasites burden the world with huge costs in terms of human and animal health. Most parasitic diseases caused by protozoans are neglected, particularly those associated with poverty and tropical countries, but the paucity of drug treatments and vaccines combined with increasing problems of drug resistance are becoming major concerns for their control and eradication. In this climate, the discovery/repurposing ...